Magnesium Sulfate Monitoring and the Nursing Triad

Magnesium sulfate for preeclampsia comes with three monitoring checks, and they are the most reliably tested thing about the drug. Neurologic status, respiratory rate, urine output. If you can say why each one is on the list, you can answer almost any item about this therapy.

The three checks, named

StatPearls, in its article on magnesium toxicity, names the monitoring for magnesium sulfate therapy in preeclampsia as neurologic status including alertness and patellar or deep tendon reflexes, respiratory rate, and urine output.

That is the sourced list. Three checks, in that grouping, and the reflexes sit inside the neurologic check rather than standing apart from it.

PN candidates meet this drug regularly, and the administration and monitoring side is exactly where PN items live. The 2026 NCLEX-PN test plan from NCSBN calls its drug category Pharmacological Therapies, and this is the shape of content that sits inside it.

Why reflexes belong to the neurologic check

Magnesium depresses neuromuscular transmission, so the nervous system is where excess magnesium announces itself first. Reflexes are the cheapest, fastest window into that.

A patellar reflex takes seconds and needs no equipment. That is why it is checked so often, not because it is the most sophisticated assessment available.

The direction of change is what you are watching. Reflexes that were present and are now diminished mean something. A single reading on its own means much less, which is why these checks are documented serially.

Respiratory rate, without the number you were probably taught

Many programs teach a specific respiratory rate that must be met before each dose. That figure circulates widely, and we could not verify it in a primary source, so we are not printing it here.

What is defensible is the assessment itself. Assess respiratory rate before and during magnesium sulfate therapy, alongside reflexes and urine output, and follow the parameters your facility publishes.

That is not a hedge for its own sake. A number quoted from memory into a chart is worse than a nurse who checks the order set. Facility parameters exist precisely so the gate is written down.

Urine output, because the kidney clears it

Magnesium is cleared renally. A patient whose urine output is falling is a patient whose magnesium is accumulating, whatever the infusion rate says.

This is why urine output belongs in a drug monitoring triad at all, which surprises people. It is not a general wellness check here. It is a clearance check.

So when a stem drops a low hourly output into an otherwise ordinary case, that detail is about the magnesium. Item writers rarely put it there by accident.

The antidote and how it is given

The published antidote for magnesium toxicity is calcium gluconate. StatPearls gives 1 to 3 g intravenously over 2 to 5 minutes, repeated if severe manifestations persist.

The antagonism is immediate but temporary. Calcium opposes magnesium's effect at the neuromuscular junction rather than removing magnesium from the body, so the underlying problem still has to be addressed.

Keep that distinction. Reversal is not clearance.

Why calcium is the antagonist

Magnesium and calcium compete at the neuromuscular junction, which is why calcium works and why it works quickly.

Magnesium in excess blocks transmission at that junction, producing the reflex loss and the respiratory depression that define the toxic picture. Calcium pushes back at the same site, and the effect appears within minutes.

The catch sits in the word temporary. Nothing about giving calcium removes magnesium from the patient, so the effect fades while the underlying problem continues. The infusion has to be addressed, and the patient stays under close observation afterwards.

Reversal buys time. It does not end the episode.

What we are deliberately not printing

There is a familiar four tier ladder of magnesium levels, each tied to a specific toxic effect, and it appears in a lot of study material. We are not reproducing it, because the version in circulation uses different units from the figure we could verify and we could not confirm the tiers themselves.

What is sourced is the sequence. Deep tendon reflexes are lost first, then respiratory depression follows, then cardiac effects. That order is the clinically useful part and it is the part items actually test.

The reasoning behind teaching the sequence rather than the cutoffs, along with the one verified threshold, is set out in magnesium toxicity, teach the sequence not the cutoffs.

Why this patient is on it in the first place

Magnesium sulfate shows up in preeclampsia with severe features, so the diagnosis behind the drug is usually part of the stem. The published severe features list, and the shortened confirmation window at severe range pressures, are in severe features and the shortcut for 160 over 110.

Knowing the indication changes how you read the monitoring. You are watching for magnesium toxicity in one direction and for the disease worsening in the other.

After delivery, the assessments change again

The newborn arrives into a room where scoring begins immediately, and the tool used for that has a narrower purpose than most people assume. What it does and does not predict is explained in the Apgar score, what it does and does not predict.

What a stem looks like

A patient receiving magnesium sulfate for preeclampsia with severe features has produced 20 mL of urine in the last hour. She is drowsy, and her patellar reflexes are harder to elicit than they were at the start of the shift.

All three checks have changed. That is not a coincidence in a stem, and it is not a coincidence at the bedside either.

Reporting is the right answer here. This patient needs the infusion reviewed by someone with the authority to change it, and she needs that now rather than at the next scheduled assessment.

The PN sized version

Three checks. Neurologic status with reflexes, respiratory rate, urine output. One antidote with a published dose, one sequence rather than a ladder of numbers, and facility parameters for the gate.

Which other obstetric and newborn content earns PN study time is set out in newborn and maternity content a PN candidate actually needs, and the broader obstetric picture is mapped in maternity and newborn questions and what is really being tested.